Cellular and Molecular Mechanisms of Chemically Induced Renal Carcinogenesis

References

• National Cancer Institute. Cancer Rates and Risks. NIH Publ. No. 85–691, 1985; 118–121
   Google Scholar
• National Cancer Institute. Cancer Statistics Review 1973–1986. 1989
   Google Scholar
• Paulson D E, Perez C A, Anderson T. Cancer of the kidney and ureter. Cancer Principles & Practice of Oncology, V T DeVita, Jr, S Hellman, S A Rosenberg. JB Lippincott, Philadelphia 1985; 895–1007
   Google Scholar
• IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall evaluations of carcinogenicity: an updating of IARC Monographs, International Agency for Research on Cancer, Lyon 1987; Vols. 1–42, Suppl. 7
   Google Scholar
• Tomatis L, Aitio A, Wilbourn J, Shuker L. Human carcinogens so far identified. Jpn J Cancer Res 1989; 80: 795–807
   PubMedGoogle Scholar
• Silverberg S G. The autopsy and cancer. Arch Pathol Lab Med 1984; 108: 476–478
   PubMed Web of Science ®Google Scholar
• Holm-Nielsen P, Olsen T S. Ultrastructure of renal adenoma. Ultrastruct Pathol 1988; 12: 27–39
   PubMed Web of Science ®Google Scholar
• Haseman J K, Huff J E, Zeiger E, McConnell E E. Comparative results of 327 chemical carcinogenicity studies. Environ Health Perspect 1987; 74: 229–235
   PubMed Web of Science ®Google Scholar
• Huff J E, McConnell E E, Haseman J K, et al. Carcinogenesis studies: results of 398 experiments on 104 chemicals from the U.S. National Toxicology Program. Ann NY Acad Sci 1988; 534: 1–30
   PubMed Web of Science ®Google Scholar
• Huff J E, Eustis S L, Haseman J K. Occurrence and relevance of chemically induced benign neoplasma in long-term carcinogenicity studies. Cancer Metastasis Rev 1989; 8: 1–21
   PubMed Web of Science ®Google Scholar
• Bach P H, Gregg N J. Experimentally induced renal papillary necrosis and upper urothelial carcinoma. International Review of Experimental Pathology, G W Richter, K Solez. Academic Press, New York 1988; 1–54
   Google Scholar
• Lipsky M M, Jr, Trump B F. Chemically induced renal epithelial neoplasia in experimental animals. International Review of Experimental Pathology, G W Richter, K Solez. Academic Press, New York 1988; 357–383
   Google Scholar
• Chu K C, Cueto C, Jr, Ward J M. Factors in the evaluation of 200 National Cancer Institute carcinogen bioassays. J Toxicol Environ Health 1981; 8: 251–280
   PubMed Web of Science ®Google Scholar
• Griesemer R A, Cueto C, Jr. Toward a classification scheme for degrees of experimental evidence for the carcinogenicity of chemicals for animals. Molecular and Cellular Aspects of Carcinogenic Screening Tests, R Montesano, B L Tomatis. IARC Scientific Publ. No. 27, Lyon 1980; 259–281
   Google Scholar
• Chhabra R S, Huff J E, Schwetz B S, Selkirk J. An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ Health Perspect 1990; 86: 313–321
   PubMed Web of Science ®Google Scholar
• Maronpot R R, Haseman J K, Boorman G A, Eustis S E, Rao G N, Huff J E. Liver lesions in B6C3F1 mice: The National Toxicology Program, experience and position. Arch Toxicol (Suppl) 1987; 10: 10–26
   PubMedGoogle Scholar
• Huff J E, Bucher J R, Haseman J K, Cirvello J D. Chemicals associated with site-specific neoplasia in 1328 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect 1991; 93: 247–270
   PubMed Web of Science ®Google Scholar
• Haseman J K, Huff J E. Species correlation in long-term carcinogenesis studies. Cancer Lett 1987; 37: 125–132
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency, Risk Assessment Forum, Alpha-2μ-globulin: synthesis, accumulation in hyaline droplets of the renal proximal tubule, and association with the production of renal toxicity and renal tumor formation in the male rat. In press
   Google Scholar
• Borghoff S J, Short B G, Swenberg J A. Biochemical mechanisms and pathobiology of α2μ-globulin nephropathy. Annu Rev Pharmacol Toxicol 1990; 30: 349–367
   PubMed Web of Science ®Google Scholar
• NTP. Technical Report on the toxicology and carcinogenesis studies of d-limonene (CAS No. 5989–27-5) in F344/N rats and B6C3F₁ mice (gavage studies). NIH Publ. No. 90–2802, January, 1990
   Google Scholar
• Swenberg J A, Short B, Borghoff S, Strasser J, Charbonneau M. The comparative pathobiology of α2μ-globulin nephropathy. Toxicol Applied Pharmacol 1989; 97: 35–46
   PubMed Web of Science ®Google Scholar
• Roy A K, Neuhaus O W. Adrogenic control of a sex-dependent protein in the rat. Nature (London) 1967; 214: 618–620
   PubMed Web of Science ®Google Scholar
• Lehman-McKeeman L D, Rodriguez P A, Takigiku R, Caudill D, Fey M L. d-Limonene-induced male rat-specific nephrotoxicity: evaluation of the association between d-limonene and α2μ-globulin. Toxicol Applied Pharmacol 1989; 99: 250–259
   PubMed Web of Science ®Google Scholar
• Suiter M A, Churnesky P, Jayaraj A, Richardson A. Metabolic activation of chemical carcinogens by kidney from rats and mice of various ages. Comp Biochem Physiol 1982; 73C: 435–438
   Google Scholar
• Hook J B, Hewitt W R. Toxic responses of the kidney. Casarett and Doull's Toxicology: The Basic Science of Poisons, C D Klaassen, M O Amdur, J Doull. Macmillan, New York 1986; 310–329
   Google Scholar
• Berndt W O, Davis M E. Renal methods for toxicology. Principles and Methods of Toxicology, A W Hayes. Raven Press, New York 1989; 629–648
   Google Scholar
• Hiasa Y, Ito N. Experimental induction of renal tumors. CRC Crit Rev Toxicol 1987; 17: 279–343
   Web of Science ®Google Scholar
• Goldstein R S, Tarloff J B, Hook J B. Age-related nephropathy in laboratory rats. FASEB J 1988; 2: 2241–2251
   PubMed Web of Science ®Google Scholar
• Kluwe W M, Abdo K M, Huff J. Chronic kidney disease and organic chemical evaluations of casual relationships in humans and experimental animals. Fundam Appl Toxicol 1984; 4: 889–901
   PubMedGoogle Scholar
• Boyd J A, Barrett J C. Genetic and cellular basis of multistep carcinogenesis. Pharmacol Ther 1990; 46: 469–486
   PubMed Web of Science ®Google Scholar
• Pitot H C, Goldsworthy T, Moran S. The natural history of carcinogensis: implication of experimental carcinogenesis in the genesis of human cancer. J Supramol Struct Cell Biochem 1981; 17: 133–146
   PubMedGoogle Scholar
• Barrett J C, Fletcher W F. Cellular and molecular mechanisms of multistep carcinogenesis in cell culture models. Mechanisms of Environmental Carcinogenesis: Multistep Models of Carcinogenesis, J C Barrett. CRC Press, Boca Raton, FL 1987; Vol. 2: 73–116, 1987
   Google Scholar
• Weinberg R A. The action of oncogenes in the cytoplasm and nucleus. Science 1985; 230: 770–776
   PubMed Web of Science ®Google Scholar
• Bishop J M. The molecular genetics of cancer. Science 1987; 235: 305–311
   PubMed Web of Science ®Google Scholar
• Knudson A G, Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985; 45: 1437–1443
   PubMed Web of Science ®Google Scholar
• Koi M, Afshari C, Annab L A, Barrett J C. Role of a tumor suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells. Proc Natl Acad Sci USA 1989; 86: 8773–8777
   PubMedGoogle Scholar
• Weissman B E. Suppression of tumorigenicity in mammalian cell hybrids. Mechanisms of Environmental Carcinogenesis, J C Barrett. CRC Press, Boca Raton, FL 1987; 31–45
   Google Scholar
• Klein G. The approaching era of the tumor suppressor genes. Science 1987; 238: 1539–1545
   PubMed Web of Science ®Google Scholar
• Cavanee W K, Dryja T P, Phillips R A, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983; 305: 779–784
   PubMed Web of Science ®Google Scholar
• Murphree A L, Benedict W F. Retinoblastoma: clues to human oncogenesis. Science 1984; 223: 1028–1033
   PubMed Web of Science ®Google Scholar
• Gateff E. Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 1978; 200: 1448–1459
   PubMedGoogle Scholar
• Vogelstein B, Fearon E R, Hamilton S R, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319: 525–532
   PubMed Web of Science ®Google Scholar
• Sager R. Genetic expression of tumor formation: new frontier in cancer research. Cancer Res 1986; 46: 1573–1580
   PubMed Web of Science ®Google Scholar
• Koi M, Barrett J C. Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells. Proc Natl Acad Sci USA 1986; 83: 5992–5996
   PubMed Web of Science ®Google Scholar
• Oshimura M, Gilmer T M, Barrett J C. Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras-plus v-myc oncogenes. Nature 1985; 316: 636–639
   PubMedGoogle Scholar
• Fujita J, Kraus M H, Onoue H, et al. Activated H-ras oncogenes in human kidney tumors. Cancer Res 1988; 48: 5251–5255
   PubMedGoogle Scholar
• Nanus D M, Mentle I R, Motzer R J, et al. Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol 1990; 143: 175–178
   PubMed Web of Science ®Google Scholar
• Nanus D M, Ebrahim S AD, Bander N H, et al. Transformation of human kidney proximal tubule cells by ras-containing retroviruses. J Exp Med 1989; 169: 953–972
   Google Scholar
• Kinouchi T, Saiki S, Naoe T, et al. Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma. Cancer Res 1989; 49: 3627–3630
   Google Scholar
• Yao M, Shuin T, Misaki H, Kubota Y. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. Cancer Res 1988; 48: 6753–6757
   PubMed Web of Science ®Google Scholar
• Slamon D J, de Kernion J B, Verma I M, Cline M J. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 236–262
   Google Scholar
• Karthaus H -FM, Schalken J A, Feitz W FJ, et al. Expression of the human fes cellular oncogene in renal cell tumors. Urol Res 1986; 14: 123–127
   Google Scholar
• Tatosyan A G, Galetzki S A, Kisseljova N P, et al. Oncogene expression in human tumors. Int J Cancer 1985; 35: 731–736
   Google Scholar
• Derynck R, Goeddel D V, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 1987; 47: 707–712
   PubMed Web of Science ®Google Scholar
• Gomella L G, Sargent E R, Wade T P, et al. Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma. Cancer Res 1989; 49: 6972–6975
   PubMed Web of Science ®Google Scholar
• Walter T A, Berger C S, Sandberg A A. The cytogenetics of renal tumors. Where do we stand, where do we go?. Cancer Genet Cytogenet 1989; 43: 15–34
   Google Scholar
• Weaver D J, Michalski K, Miles J. Cytogenetic analysis in renal cell carcinoma: Correlation with tumor aggressiveness. Cancer Res 1988; 48: 2887–2889
   Google Scholar
• Cin P D, Sandberg A A, Huben R, et al. New cytogenetic subtype of renal tumors. Cancer Genet Cytogenet 1988; 32: 313
   Google Scholar
• Miles J, Michalski K, Kouba M, Weaver D J. Genomic defects in nonfamilial renal cell carcinoma. Possible specific chromosome change. Cancer Genet Cytogenet 1988; 34: 135–142
   Google Scholar
• Vanni R, Nieddu M, Scarpa R M, et al. Trisomy 7 in a case of transitional cell carcinoma of the kidney. Cancer Genet Cytogenet 1989; 41: 149–151
   Google Scholar
• Collard J G, van de Poll M, Scheffer A, et al. Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Res 1987; 47: 666–6670
   Google Scholar
• Cohen A J, Li F P, Berg S, Marchetto D J, et al. Hereditary renal cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979; 301: 592–596
   PubMed Web of Science ®Google Scholar
• Pathak S, Strong L C, Ferrell R E, Trindade A. Familial renal cell carcinoma with a 3 11 chromosome translocation limited to tumor cells. Science 1982; 217: 939–941
   PubMed Web of Science ®Google Scholar
• Drabkin H A, Bradley C, Hart I, et al. Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation. Proc Natl Acad Sci USA 1985; 82: 6980–6984
   Google Scholar
• Harris P, Morton C C, Guglielmi P, et al. Mapping by chromosome sorting of several gene probes, including c-myc, to the derivative chromosomes of a 3;8 translocation associated with familial renal cancer. Cytometry 1986; 7: 589–594
   Google Scholar
• Yoshida M A, Ohyashiki K, Ochi H, et al. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res 1986; 46: 2139–2147
   PubMed Web of Science ®Google Scholar
• Teyssier J R, Henry I, Dozier C, et al. Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus. J Natl Cancer Inst 1986; 77: 1187–1195
   PubMedGoogle Scholar
• Kovacs G, Szücs S, De Riese W, Baumgartel H. Specific chromosome aberration in human renal cell carcinoma. Int J Cancer 1987; 40: 171–178
   PubMed Web of Science ®Google Scholar
• Teyssier J -R. What is the genetic mechanism underlying the recurrent 3p rearrangement in human renal cell carcinoma?. Cancer Genet Gytogenet 1987; 25: 179–181
   Google Scholar
• van der Hout A H, Kok K, van den Berg A, et al. Direct molecular analysis of a deletion of 3p in tumors from patients with sporadic renal cell carcinoma. Cancer Genet Cytogenet 1988; 32: 281–285
   Google Scholar
• Kovacs G, Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 1989; 49: 651–659
   Google Scholar
• Seizinger B R, Rouleau G A, Ozelius L J, et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988; 332: 268–269
   PubMed Web of Science ®Google Scholar
• Shimizu M, Yokota J, Mori N, et al. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell line YCR. Oncogene 1990; 5: 184–194
   Google Scholar
• Kirkman H, Bacon R L. Estrogen-induced tumors of the kidney. I. Incidence of renal tumors in intact and gonadectomized male golden hamsters treated with diethylstilbestrol. J Natl Cancer Inst 1952; 13: 745–755
   PubMedGoogle Scholar
• Li J J, Li S A, Oberley T, . Estrogen carcinogenicity: hormonal, morphologic and chemical interactions. Chemical Carcinogens. Activation Mechanisms, Structural and Electronic Factors, and Reactivity, P Politzer, F J Martin, Jr, et al. Elsevier, New York 1988; 312–321
   Google Scholar
• Li J J, Li S A, Klicka J K, et al. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res 1983; 43: 5200–5204
   PubMed Web of Science ®Google Scholar
• Liehr J G. 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol Pharmacol 1983; 23: 278–281
   PubMed Web of Science ®Google Scholar
• Li S A, Klicka J K, Li J J. Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implication for estrogen carcinogenesis in the hamster kidney. Cancer Res 1985; 45: 181–185
   PubMed Web of Science ®Google Scholar
• Liehr J G. Modulation of estrogen-induced carcinogenesis by chemical modifications. Arch Toxicol 1983; 55: 119–122
   Google Scholar
• McLachlan J A, Wong A, Degen G H, Barrett J C. Morphological and neoplastic transformation of Syrian hamster embryo cells by diethylstilbestrol and its analogs. Cancer Res 1982; 42: 3040–3045
   PubMed Web of Science ®Google Scholar
• Purdy R H. Carcinogenic potential of estrogen in some mammalian model system. Prog Cancer Res Ther 1984; 31: 401–415
   Google Scholar
• Metzler M, McLachlan J A. Is diethylstilbestrol bioactivated through peroxidase-mediated oxidation?. J Environ Pathol Toxicol 1978; 1: 531–533
   PubMed Web of Science ®Google Scholar
• Metzler M, McLachlan J A. The metabolism of diethylstilbestrol. CRC Crit Rev Biochem 1981; 10: 171–212
   PubMed Web of Science ®Google Scholar
• Li J J, Li S A. High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed α-naphthoflavone: a new tumor model. J Natl Cancer Inst 1984; 73: 543–547
   PubMedGoogle Scholar
• Metzler M. Diethylstilbestrol: reactive metabolites derived from a hormonally active compound. Biochemical Basis of Chemical Carcinogensis, H Greim, K Jung, M Karmer, et al. Raven Press, New York 1984; 69–75
   Google Scholar
• Glatt H R, Metzler M, Oesch F. Diethylstilbestrol and 11 derivatives: a mutagenicity study with Salmonella typhimurium. Mutat Res 1979; 67: 113–121
   PubMed Web of Science ®Google Scholar
• Lang R, Redmann U. Non-mutagenicity of some sex hormones in the Arnes Salmonella/microsome mutagenicity test. Mutat Res 1979; 67: 361–365
   PubMedGoogle Scholar
• Rudiger H W, Haenisch F, Metzler M, et al. Metabolites of diethylstilbestrol induce sister chromatid exchanges in human cultured fibroblasts. Nature 1979; 281: 392–394
   PubMed Web of Science ®Google Scholar
• Barrett J C, McLachlan J A, Elmore E. Inability of diethylstilbestrol to induce 6-thioguanine-resistant mutants and to inhibit metabolic cooperation of V79 Chinese hamster cells. Mutat Res 1982; 107: 427–432
   Google Scholar
• Barrett J C, Wong A, McLachlan J A. Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science 1981; 212: 1402–1404
   PubMed Web of Science ®Google Scholar
• Drevon C, Piccoli C, Montesano R. Mutagenicity assays of estrogenic hormones in mammalian cells. Mutat Res 1981; 89: 83–90
   PubMedGoogle Scholar
• Kinsella A R. Elimination of metabolic co-operation and the induction of sister chromatid exchanges are not properties common to all promoting or co-carcinogenic agents. Carcinogenesis 1982; 3: 499–503
   PubMed Web of Science ®Google Scholar
• Myhr B, Bowers L, Caspary W J. Assays for the induction of gene mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells in culture. Progress in Mutation Research, J Ashby, F J deSerres. Elsevier, Amsterdam 1985; 555–568
   Google Scholar
• Clive D, Johnson K O, Spector J FS, et al. Validation and characterization of the L5178Y TK+/- mouse lymphoma mutagen assay system. Mutat Res 1979; 59: 61–108
   PubMed Web of Science ®Google Scholar
• Martin C N, McDermid A C, Garnder R C. Testing of known carcinogens and non-carcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. Cancer Res 1978; 38: 2621–2627
   PubMed Web of Science ®Google Scholar
• Althaus F R, Lawrence S D, Sattler G L, et al. Chemical quantification of unscheduled DNA synthesis in cultured hepatocytes as an assay for the rapid screening of potential chemical carcinogens. Cancer Res 1982; 42: 3010–3015
   PubMedGoogle Scholar
• Hill A, Wolff S. Increased induction of sister chromatid exchange by diethylstilbestrol in lymphocytes from pregnant and premenopausal women. Cancer Res 1982; 42: 893–896
   PubMedGoogle Scholar
• Abe S, Sasaki M. Chromosome aberrations and sister chromatid exchanges in Chinese hamster cells exposed to various chemicals. J Natl Cancer Inst 1977; 58: 1635–1641
   PubMed Web of Science ®Google Scholar
• Tsutsui T, Degen G H, Schiffman D, et al. Dependence of exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethylstilbestrol and related compounds. Cancer Res 1984; 44: 184–189
   Google Scholar
• Degen G H, Wong A, Eling T E, et al. Involvement of prostaglandin synthetase in the peroxidative metabolism of diethylstilbestrol in Syrian hamster embryo fibroblast cell cultures. Cancer Res 1983; 43: 992–996
   PubMedGoogle Scholar
• Naylor P H, Rabinder N K, Loring J M, Villee C A. The estrogen-induced/dependent renal adenocarcinoma of the Syrian hamster. Regulation of Gene Expression by Hormones, K W McKerns. Plenum Press, New York 1983; 39–50
   Google Scholar
• Liehr J G, Randerath K, Randerath E. Target organ-specific covalent DNA damae preceding diethylstilbestrol-induced carcinogensis. Carcinogenesis 1985; 6: 1067–1069
   PubMed Web of Science ®Google Scholar
• Sato Y, Murai T, Tsumuraya M, et al. Disruptive effects of diethylstilbestrol on microtubules. Gann 1984; 75: 1046–1048
   Google Scholar
• Sharp D C, Parry J M. Diethylstilbestrol: the binding and effects of diethylstilbestrol upon the polymerisation of purified microtubule protein in vitro. Carcinogenesis 1985; 6: 865–872
   PubMed Web of Science ®Google Scholar
• Tucker R W, Barrett J C. Decreased numbers of spindle and cytoplasmic microtubules in hamster embryo cells treated with a carcinogen, diethylstilbestrol. Cancer Res 1986; 42: 2088–2095
   Google Scholar
• Oshimura M, Barrett J C. Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. Environ Mutagen 1986; 8: 129–159
   PubMedGoogle Scholar
• Kuchler R J, Graver R C. Effects of natural estrogens on L strain fibroblasts in tissue culture. Proc Soc Exp Biol Med 1982; 110: 287–292
   Google Scholar
• Rao P N, Engelberg J. Structural specificity of estrogens in the induction of mitotic chromatid non-disjunction in HeLa cells. Exp Cell Res 1967; 48: 71–81
   Google Scholar
• Lycette R R, Whyte S, Chapman C J. Aneuploid effects of oestradiol on cultured human synovial cells. N Z Med J 1970; 72: 114–117
   Google Scholar
• Chrisman C L. Aneuploidy in mouse embryos induced by diethylstilbestrol diphosphate. Teratology 1974; 9: 229–232
   Google Scholar
• Chrisman C L, Hinkle L L. Induction of aneuploidy in mouse bone marrow cells with diethylstilbestrol-diphosphate. Can J Genet Cytol 1974; 16: 831–835
   Google Scholar
• Chrisman C L, Lasley J F. Effects of diethylstilbestrol diphosphate on mitotic activity in bovine lymphocyte cultures. Cytologia 1975; 40: 817–821
   Google Scholar
• McGaughey R W. The culture of pig oocytes in minimal medium, and the influence of progesterone and estradiol-17β on meiotic maturation. Endocrinololgy 1977; 100: 39–45
   Google Scholar
• Sawada M, Ishidate M, Jr. Colchicine-like effect of diethylstilbestrol (DES) on mammalian cells in vitro. Mutat Res 1978; 57: 175–182
   Google Scholar
• Parry J M, Parry E M, Barrett J C. Tumour promoters induce mitotic aneuploidy in yeast. Nature 1981; 294: 263–265
   PubMed Web of Science ®Google Scholar
• Danford N, Parry J M. Abnormal cell division in cultured human fibroblasts after exposure to diethylstilbestrol. Mutat Res 1982; 103: 379–383
   Google Scholar
• Tsutsui T, Maizumi H, McLachlan J A, Barrett J C. Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosome mechanism in carcinogenesis. Cancer Res 1983; 43: 3814–3821
   PubMed Web of Science ®Google Scholar
• Barrett J C, Oshimura M, Tsutsui T, Tanaka N. Role of aneuploidy in early and late stages of neoplastic progression of Syrian hamster embryo cells in culture. Aneuploidy: Etiology and Mechanisms, V L Dellarco, R E Voytek, A Hollaender. Plenum Press, New York 1985; 523–538
   Google Scholar
• Satya-Prakash K L, Hsu T C, Wheeler W J. Metaphase arrest, anaphase recovery and aneuploidy induction in cultured Chinese hamster cells following exposure to mitotic arrestants. Anticancer Res 1984; 4: 351–356
   Google Scholar
• Barrett J C, Wong A, McLachlan J A. Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science 1981; 212: 1402–1404
   PubMed Web of Science ®Google Scholar
• Pienta R J. Transformation of Syrian hamster embryo cells by diverse chemicals and correlation with their reported carcinogenic and mutagenic activities. Chemical Mutagens, F J deSerres. Plenum Publishing Corp., New York 1980; 175–202
   Google Scholar
• Fu Y S, Robboy S J, Prat J. Nuclear DNA study of vaginal and cervical squamous cell abnormalities in DES-exposed progeny. J Obstet Gynecol 1978; 52: 129–137
   Google Scholar
• Neuhaus O W, Flory W, Biswas N, Hollerman C E. Urinary excretion of α-2μ-globulin and albumin by adult male rats following treatment with nephrotoxic agents. Nephron 1981; 28: 133–140
   PubMedGoogle Scholar
• Persner J, Reed R R, Feinstein P G, Synder S H. Molecular cloning of odorant-binding protein: member of a ligand carrier family. Science 1988; 241: 336–339
   Google Scholar
• Cavaggioni A, Sorbl R T, Heen J N, Pappin D JC, Findlay C BC. Homology between the pyrazine-binding protein from nasal mucosa and major urinary proteins. FEBS Lett 1987; 212: 225–226
   PubMedGoogle Scholar
• Halder C A, Holdsworth C E, Cockrell B Y, Piccirillo V J. Hydrocarbon nephropathy in male rats: identification of the nephrotoxic components of unleaded gasoline. Toxicol Indust Health 1985; 1: 67–87, 128
   PubMedGoogle Scholar
• HEI: An update on gasoline vapor exposure and human cancer—An evaluation of scientific information published between 1985 and 1987. Health Effects Institute, Report of the Institute's Health Review Committee, January 6, 1988
   Google Scholar
• Goldsworthy T L, Lyght O, Burnett V L, Popp J A. Potential role of α-2μ-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane. Toxicol Appl Pharmacol 1988; 96: 367–379
   PubMed Web of Science ®Google Scholar
• Moolgavkar S H, Knudson A G, Jr. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst 1981; 66: 1037–1052
   PubMed Web of Science ®Google Scholar
• Clayson D B, Nera E A, Lok E. The potential for the use of cell proliferation studies in carcinogen risk assessment. Regul Toxicol Pharmacol 1989; 9: 284–295
   PubMedGoogle Scholar
• Barrett J C. A multistep model for neoplastic development: role of genetic and epigenetic changes. Mechanisms of Environmental Carcinogenesis: Multistep Models of Carcinogenesis, J C Barrett. CRC Press, Boca Raton, FL 1987; Vol. 2: 117–126
   Google Scholar
• Vesselinovitch S D, Rao K VN, Mihailovich N. Neoplastic response of mouse tissue during perinatal age periods and its significance in chemical carcinogenesis. J Natl Cancer Inst 1979; 51: 239–245
   Google Scholar
• Ames B N. Endogeneous oxidative DNA damage aging, and cancer. Free Rad Res Commun 1989; 7: 121–128
   PubMedGoogle Scholar
• Loeb L A. Endogenous carcinogenesis: molecular oncology into the twenty-first century—presidential address. Cancer Res 1989; 49: 5489–5496
   PubMed Web of Science ®Google Scholar
• Hoel D G, Haseman J K, Hogan M D, et al. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis 1988; 9: 2045–2052
   PubMed Web of Science ®Google Scholar
• Ledda-Columbano G M, Columbano A, Curto M, et al. Further evidence that mitogen-induced proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis 1989; 10: 847–850
   PubMed Web of Science ®Google Scholar
• Eker R, Mossige J, Johannessen J V, Aars H. Hereditary renal adenomas and adenocarcinornas in rats. Diagnostic Histopathology 1981; 4: 99–110
   PubMedGoogle Scholar
• Barrett J C, Huff J E. Cellular and molecular mechanisms of chemically induced renal carcinogenesis. Nephrotoxicity: Mechanisms, Early Diagnosis, and Therapeutic Management, P H Bach, N J Gregg, M F Wiks, L Delacruz. Dekker, New York 1991; 287–306
   Google Scholar
• Huff J E. Carcinogenicity of ochratoxin A in experimental animals. Mycotoxins, Endemic Nephropathy, and Urinary Tract Tumours. IARC Sci. Pub. 113, International Aency for Research on Cancer, LyonFrance, 1–16
   Google Scholar
• Barrett J C. Mechanism of action of known human carcinogenes. Mechanisms of Carcinogenesis in Risk Evaluation, H Vainio, P Magee, D McGregor, A J McMichael. IARC Sci. publ. 116, International Agency for Research on Cancer, LyonFrance 1992, in press
   Google Scholar
• Huff J E. Chemical toxicity and chemical caricnogenesis. Is there a causal connection?. Mechanisms of Caricnogenesis in Risk Evaluation, H Vainio, P Magee, D McGregor, A J McMichael. IARC Sci. Publ. 116, International Gency for Research on Cancer, LyonFrance 1992, in press
   Google Scholar